High Dose Lurasidone for Patients With Treatment Resistant Schizophrenia

NCT01569659 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
101
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Northwestern University

Collaborators